Mounjaro Price News: What Changed in 2025 and What It Means for You

What Eli Lilly's official UK price change actually shows

The figures that circulated in August and September 2025 came from Eli Lilly's own published list price adjustments for the UK market, not from a single clinic setting its margins. At the lower doses (2.5mg and 5mg) the list price increase was smaller in absolute terms; at the higher therapeutic doses, the gap was far larger. As a reference point, the widely reported figure for the 15mg pen moved from approximately £122 to approximately £330. These are manufacturer list prices, not necessarily what any individual pharmacy charges, but they set the floor that private providers work from.

The change did not affect NHS prescribing costs for patients directly, since NHS supply runs through separate contractual arrangements. For people using a private regulated pharmacy, though, the September 2025 news is the reason prices look different now compared with early 2025 comparisons still circulating online. If you are comparing quotes and see a dramatic outlier well below current market rates, that gap is worth interrogating carefully, and our updated breakdown of the Mounjaro 5mg new price is a useful starting point for understanding exactly where the lower-dose figures now sit. Our full breakdown of the Mounjaro price increase covers the dose-by-dose context in more detail.

What a quoted Mounjaro price may or may not include

A monthly price for a prescription weight-loss medicine is not quite like a monthly gym membership. The quoted number can mean very different things depending on what the clinic bundles in. Some providers list the pen price alone and add a separate consultation fee, sometimes charged per appointment, sometimes as a monthly platform fee. Prescription fees may appear as a line item at checkout. Delivery charges vary from free to £10 or more per order, and the courier speed differs. Aftercare (someone to contact if you feel unwell, guidance when moving between doses, a clinical review before each repeat) may cost extra or may not exist at all.

That is not a criticism of any particular provider; it is just how the market is structured. The practical implication for a patient is that a lower headline figure can become a higher actual cost once all the components are added. Reading the full breakdown before committing is worth the five minutes, and our page covering the new Mounjaro prices across all doses sets out what the current market looks like so you have a reliable baseline for comparison. You can find current Mounjaro price context alongside what each component of a private service typically covers.

Where nume sits, and why we say it plainly

One transparent price. That is the short version. At nume, the consultation is free, the prescription is free, delivery is free and arrives the next working day via DPD in plain packaging, and aftercare runs seven days a week as standard. There are no subscriptions and no auto-renewals; every repeat order goes through a fresh clinical review by a GPhC-registered Independent Prescriber before anything is dispatched. The same-day review process (order by 12pm Monday to Friday and your case is reviewed that day, not queued for the following week) matters especially if you time your order around a payday, a long weekend or a bank holiday.

We are not the cheapest option. That is a deliberate position. The treatment itself is a prescription medicine, and the clinical infrastructure around it (identity verification, live weight confirmation on video, GP notification, Summary Care Record checks, evidence review for dose increases) exists because those steps protect you. We'd rather explain the price once than explain a gap in care later. Our Mounjaro price page shows current treatment pricing; the consultation page is where your prescriber assessment starts.

Why 'cheapest' is the wrong measure for a prescription medicine

This is stated plainly on the MHRA's public guidance on GLP-1 medicines, and the enforcement record backs it up. In October 2025 the MHRA raided the first illicit UK manufacturing site producing counterfeit tirzepatide pens, in Northampton. Across 2025 as a whole, around 20 million doses of illegally traded weight-loss medicines with a street value of approximately £45 million were seized. Counterfeit pens have contained insulin instead of tirzepatide, a substitution that could cause a serious hypoglycaemic episode in someone who has no idea what they injected.

The safe route is a prescription from a qualified prescriber, dispensed by a pharmacy you can verify. Any GPhC-registered pharmacy is listed on the GPhC's public register; nume's premises registration number is 9012878. The MHRA's guidance makes clear that sellers offering these medicines without a prescription, at prices far below the market, or through social media channels are red flags, not bargains. For a fuller picture of how to identify a legitimate supplier, the Mounjaro overview page covers the supply chain question directly.

Price is a reasonable question. For a prescription-only medicine, it just isn't the primary one. The right questions are: is this pharmacy verifiable, is a real clinician reviewing my case, and is the medicine coming from the licensed UK supply chain? If all three answers are yes, the price question becomes much easier to evaluate. Start your free consultation and a prescriber will review your case the same day.